Influence of oestrogenic hormones on carcinogenesis and toxicity of radiostrontium.
D000818:Animals; D001846:Bone Development / Q000187:drug effects / Q000528:radiation effects*; D001859:Bone Neoplasms / Q000209:etiology* / Q000473:pathology; D002455:Cell Division / Q000187:drug effects / Q000528:radiation effects; D003692:Delayed-Action Preparations; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D008297:Male; D009374:Neoplasms, Experimental; D009381:Neoplasms, Radiation-Induced / Q000209:etiology* / Q000401:mortality / Q000473:pathology; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000494:pharmacology; D010006:Osteoblasts / Q000187:drug effects / Q000528:radiation effects; D010010:Osteoclasts / Q000187:drug effects / Q000528:radiation effects; D012516:Osteosarcoma / Q000209:etiology* / Q000473:pathology; D011108:Polymers / Q000008:administration & dosage / Q000494:pharmacology; D011830:Radiation Effects; D051381:Rats; D013326:Strontium Radioisotopes; D013997:Time Factors
D003692:Delayed-Action Preparations; D009943:Organophosphorus Compounds; D011108:Polymers; D013326:Strontium Radioisotopes; D004958:Estradiol